Who Uses Risk Based Monitoring Technology?

As the FDA continues to push for more risk-based monitoring, companies are scrambling to find the right solution. See who’s using what.

Checkout this video:

Pharmaceutical and Biotech Companies

Pharmaceutical companies and biotech companies are increasingly turning to risk based monitoring (RBM) technology to gain a competitive edge and improve patient safety. RBM is a data-driven approach that uses real-time data to identify and address risks across the product life cycle, from development to post-marketing.

By identifying and addressing risks early, RBM can help pharmaceutical and biotech companies bring new products to market faster and improve patient safety. RBM is also being used to improve the efficiency of clinical trials, reduce the cost of clinical research, and generate real-time insights that can inform decision making.

Pharmaceutical and biotech companies are not the only ones using RBM technology. Regulatory agencies, such as the US Food and Drug Administration (FDA), are also using RBM to improve the efficiency of their inspections and investigations. In addition, payers and providers are using RBM to inform coverage decisions and improve patient outcomes.

Contract Research Organizations

Contract research organizations (CROs) that provide clinical research services to the biopharmaceutical and medical device industries increasingly use risk-based monitoring (RBM) approaches and technologies as a way to more efficiently allocate monitors to sites and patients in studies. RBM is also being used by some in-house clinical research departments within drug companies.

Academic Institutions

Academic institutions are increasingly turning to risk-based monitoring (RBM) of clinical trials to comply with regulations, reduce costs, and improve outcomes. Many sponsors and contract research organizations (CROs) have already implemented RBM, but there is still confusion about who uses RBM and how it is being used.

RBM is a data-driven approach to clinical trial monitoring that focuses on identifying and addressing potential problems early, before they can lead to costly delays or serious safety issues. The goal of RBM is to improve the quality of data and the efficiency of clinical trials by reducing superfluous on-site visits and focusing monitoring efforts on areas of highest risk.

There are several different software platforms available to help sponsors and CROs implement RBM, but they all share common features. RBM platforms typically include a centralized data repository, a risk assessment tool, and a project management tool.

The centralized data repository allows users to track all trial data in one place. This can be useful for identifying trends or patterns that may indicate a problem. The risk assessment tool allows users to identify which sites or subjects are at highest risk for problems. The project management tool helps users track progress and keep track of tasks that need to be completed.

RBM platforms vary in terms of cost and complexity, but all offer benefits over traditional trial monitoring approaches. For sponsors and CROs who are looking to improve the efficiency and quality of their clinical trials, RBM is worth considering.

Government Agencies

Government agencies at all levels are turning to risk based monitoring technology to help them improve the efficiency and effectiveness of their operations. Among the many benefits of using this type of technology are the ability to focus on areas of highest risk, identify potential problems before they happen, and reduce the overall costs of government operations.

Clinical Investigators

Risk based monitoring (RBM) is a data-driven approach to clinical trial quality that is being adopted by an ever-increasing number of sponsors and contract research organizations (CROs). RBM leverages available technology and data to more efficiently and effectively monitor clinical trials, without compromising data quality or patient safety.

One key group that is using RBM technology is clinical investigators. Investigators are using RBM as a tool to more efficiently manage their workload while still providing high quality care to patients. In one study, investigators reported that they were able to complete their site visits in half the time with RBM. Investigators also felt that RBM allowed them to focus on the most important aspects of the trial, such as patient safety.

RBM is not only being used by investigators, but also by sponsors and CROs. In fact, many sponsors and CROs are now requiring that sites use RBM in order to participate in their trials. This trend is likely to continue as RBM becomes more widely adopted in the clinical research community.


Risk Based Monitoring (RBM) is a process that uses data and analytics to identify which patients may benefit the most from clinical interventions. By targeting those at highest risk, RBM can help improve patient outcomes and save lives.

RBM technology is used by a variety of healthcare organizations, including hospitals, clinics, home health agencies, and skilled nursing facilities. It is also used by pharmaceutical companies and clinical research organizations to monitor the safety and efficacy of new drugs and therapies.


Risk based monitoring technology is commonly used by caregivers to track and manage the health and well-being of patients. This type of technology can help caregivers to more effectively monitor patients, identify potential health risks, and provide timely interventions. Additionally, risk based monitoring technology can help to improve communication between caregivers and patients, as well as between different care teams.


Healthcare providers, such as physicians, use risk based monitoring (RBM) to make treatment decisions for their patients. RBM technology helps them to assess and monitor a patient’s individual risk factors for developing certain diseases or conditions. This information can then be used to customize treatment plans and make recommendations for lifestyle changes that may help to prevent or delay the onset of these conditions.


Nurses play a vital role in patient care and are often the first line of defense against potential health problems. They are also responsible for ensuring that patients receive the best possible care by monitoring their condition and providing early intervention when necessary. In recent years, nurses have increasingly relied on technology to help them do their job more effectively.

One type of technology that has become increasingly popular among nurses is risk based monitoring (RBM) technology. RBM technology is designed to help nurses identify patients who are at risk for developing adverse events so that they can provide early intervention and prevent these events from occurring.

There are a number of different RBM platforms available, but they all share some common features. First, RBM platforms use data from a variety of sources to identify patients who are at risk for adverse events. These data sources can include patient medical records, lab results, vital signs, and prescription data. Second, RBM platforms use algorithms to score patients based on their level of risk. These scores can help nurses prioritize patients who require more close monitoring. Finally, RBM platforms typically provide alerts to nurses when a patient’s risk score changes so that they can take appropriate action.

RBM technology has been shown to be effective in reducing the incidence of adverse events in hospital settings. In one study, the use of an RBM platform was associated with a 50% reduction in the incidence of adverse events among high-risk patients. Given the potential benefits of RBM technology, it is likely that we will see more nurses using this type of platform in the future.


Risk-based monitoring (RBM) is an approach to clinical trials data collection and analysis that is designed to reduce risk, improve efficiency, and enhance quality. RBM has been shown to improve the quality and efficiency of clinical trials, and pharmacist involvement in RBM is critical to success.

Pharmacists play a key role in RBM by identifying risks, developing mitigation strategies, and continuously monitoring trial progress. In addition, pharmacists are uniquely positioned to provide oversight of medication use in clinical trials and to ensure that medications are used safely and effectively.

The use of RBM technology is growing rapidly in the pharmaceutical industry, and pharmacists are well positioned to take advantage of this technology to improve the quality and efficiency of clinical trials.

Scroll to Top